Selected research
Industry Growth & Trends
Global Cardiovascular Device Testing Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Cardiovascular Device Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cardiovascular Device Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cardiovascular Device Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cardiovascular Device Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Cardiovascular Device Testing Service market include TÜV SÜD, ViVitro Labs, STC Group, Intertek, NAMSA, BDC Laboratories, MET Labs, SGS SA and Nelson Labs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cardiovascular Device Testing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cardiovascular Device Testing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cardiovascular Device Testing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cardiovascular Device Testing Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Cardiovascular Device Testing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cardiovascular Device Testing Service Market by Company
TÜV SÜD
ViVitro Labs
STC Group
Intertek
NAMSA
BDC Laboratories
MET Labs
SGS SA
Nelson Labs
Charles River Laboratories
UL Solutions
MED Institute
Eurofins Scientific
Pharmaron
Pace Analytical
Porsolt
Medical Murray
Measurlabs
RQM+
Laboratory Testing
Infinity Laboratories
Ibex Preclinical Research
Innovatech Labs
Cardiovascular Device Testing Service Segment by Type
Mechanical Testing
Physical Testing
Environmental Testing
Biocompatibility Testing
Performance Testing
Electromagnetic Compatibility (EMC) Testing
Preclinical Testing
Clinical Testing
Others
Cardiovascular Device Testing Service Segment by Application
Interventional Devices
Implantable Devices
Diagnostic and Monitoring Devices
Extracorporeal Circulation and Support Devices
Vascular Access and Suture Devices
Others
Cardiovascular Device Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Device Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Device Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Device Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Cardiovascular Device Testing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Mechanical Testing
- Physical Testing
- Environmental Testing
- Biocompatibility Testing
- Performance Testing
- Electromagnetic Compatibility (EMC) Testing
- Preclinical Testing
- Clinical Testing
- Others
Applications
- Interventional Devices
- Implantable Devices
- Diagnostic and Monitoring Devices
- Extracorporeal Circulation and Support Devices
- Vascular Access and Suture Devices
- Others
Companies covered
- TÜV SÜD
- ViVitro Labs
- STC Group
- Intertek
- NAMSA
- BDC Laboratories
- MET Labs
- SGS SA
- Nelson Labs
- Charles River Laboratories
- UL Solutions
- MED Institute
- Eurofins Scientific
- Pharmaron
- Pace Analytical
- Porsolt
- Medical Murray
- Measurlabs
- RQM+
- Laboratory Testing
- Infinity Laboratories
- Ibex Preclinical Research
- Innovatech Labs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Cardiovascular Device Testing Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Cardiovascular Device Testing Service Market Size by Region (2021-2032)
- 1.4.1 Global Cardiovascular Device Testing Service Market Size by Region (2021-2026)
- 1.4.2 Global Cardiovascular Device Testing Service Market Size by Region (2027-2032)
- 1.5 Key Regions Cardiovascular Device Testing Service Market Size (2021-2032)
- 1.5.1 North America Cardiovascular Device Testing Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Cardiovascular Device Testing Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Cardiovascular Device Testing Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Cardiovascular Device Testing Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Cardiovascular Device Testing Service Market Size Growth Rate (2021-2032)
2 Cardiovascular Device Testing Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Mechanical Testing
- 2.1.2 Physical Testing
- 2.1.3 Environmental Testing
- 2.1.4 Biocompatibility Testing
- 2.1.5 Performance Testing
- 2.1.6 Electromagnetic Compatibility (EMC) Testing
- 2.1.7 Preclinical Testing
- 2.1.8 Clinical Testing
- 2.1.9 Others
- 2.2 Global Cardiovascular Device Testing Service Market Size by Type
- 2.2.1 Global Cardiovascular Device Testing Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Cardiovascular Device Testing Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Cardiovascular Device Testing Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Cardiovascular Device Testing Service Market Size by Regions
- 2.3.1 North America Cardiovascular Device Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Cardiovascular Device Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Cardiovascular Device Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Cardiovascular Device Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Cardiovascular Device Testing Service Market Size Breakdown by Type (2021-2026)
3 Cardiovascular Device Testing Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Interventional Devices
- 3.1.2 Implantable Devices
- 3.1.3 Diagnostic and Monitoring Devices
- 3.1.4 Extracorporeal Circulation and Support Devices
- 3.1.5 Vascular Access and Suture Devices
- 3.1.6 Others
- 3.2 Global Cardiovascular Device Testing Service Market Size by Application
- 3.2.1 Global Cardiovascular Device Testing Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Cardiovascular Device Testing Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Cardiovascular Device Testing Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Cardiovascular Device Testing Service Market Size by Regions
- 3.3.1 North America Cardiovascular Device Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Cardiovascular Device Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Cardiovascular Device Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Cardiovascular Device Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Cardiovascular Device Testing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Cardiovascular Device Testing Service Industry Trends
- 4.2 Cardiovascular Device Testing Service Industry Drivers
- 4.3 Cardiovascular Device Testing Service Industry Opportunities and Challenges
- 4.4 Cardiovascular Device Testing Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Cardiovascular Device Testing Service Revenue (2021-2026)
- 5.2 Global Cardiovascular Device Testing Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Cardiovascular Device Testing Service Key Company Headquarters & Area Served
- 5.4 Global Cardiovascular Device Testing Service Company, Product Type & Application
- 5.5 Global Cardiovascular Device Testing Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Cardiovascular Device Testing Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Cardiovascular Device Testing Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Cardiovascular Device Testing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 TÜV SÜD
- 6.1.1 TÜV SÜD Company Information
- 6.1.2 TÜV SÜD Business Overview
- 6.1.3 TÜV SÜD Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 TÜV SÜD Cardiovascular Device Testing Service Product Portfolio
- 6.1.5 TÜV SÜD Recent Developments
- 6.2 ViVitro Labs
- 6.2.1 ViVitro Labs Company Information
- 6.2.2 ViVitro Labs Business Overview
- 6.2.3 ViVitro Labs Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 ViVitro Labs Cardiovascular Device Testing Service Product Portfolio
- 6.2.5 ViVitro Labs Recent Developments
- 6.3 STC Group
- 6.3.1 STC Group Company Information
- 6.3.2 STC Group Business Overview
- 6.3.3 STC Group Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 STC Group Cardiovascular Device Testing Service Product Portfolio
- 6.3.5 STC Group Recent Developments
- 6.4 Intertek
- 6.4.1 Intertek Company Information
- 6.4.2 Intertek Business Overview
- 6.4.3 Intertek Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Intertek Cardiovascular Device Testing Service Product Portfolio
- 6.4.5 Intertek Recent Developments
- 6.5 NAMSA
- 6.5.1 NAMSA Company Information
- 6.5.2 NAMSA Business Overview
- 6.5.3 NAMSA Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 NAMSA Cardiovascular Device Testing Service Product Portfolio
- 6.5.5 NAMSA Recent Developments
- 6.6 BDC Laboratories
- 6.6.1 BDC Laboratories Company Information
- 6.6.2 BDC Laboratories Business Overview
- 6.6.3 BDC Laboratories Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 BDC Laboratories Cardiovascular Device Testing Service Product Portfolio
- 6.6.5 BDC Laboratories Recent Developments
- 6.7 MET Labs
- 6.7.1 MET Labs Company Information
- 6.7.2 MET Labs Business Overview
- 6.7.3 MET Labs Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 MET Labs Cardiovascular Device Testing Service Product Portfolio
- 6.7.5 MET Labs Recent Developments
- 6.8 SGS SA
- 6.8.1 SGS SA Company Information
- 6.8.2 SGS SA Business Overview
- 6.8.3 SGS SA Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 SGS SA Cardiovascular Device Testing Service Product Portfolio
- 6.8.5 SGS SA Recent Developments
- 6.9 Nelson Labs
- 6.9.1 Nelson Labs Company Information
- 6.9.2 Nelson Labs Business Overview
- 6.9.3 Nelson Labs Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Nelson Labs Cardiovascular Device Testing Service Product Portfolio
- 6.9.5 Nelson Labs Recent Developments
- 6.10 Charles River Laboratories
- 6.10.1 Charles River Laboratories Company Information
- 6.10.2 Charles River Laboratories Business Overview
- 6.10.3 Charles River Laboratories Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Charles River Laboratories Cardiovascular Device Testing Service Product Portfolio
- 6.10.5 Charles River Laboratories Recent Developments
- 6.11 UL Solutions
- 6.11.1 UL Solutions Company Information
- 6.11.2 UL Solutions Business Overview
- 6.11.3 UL Solutions Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 UL Solutions Cardiovascular Device Testing Service Product Portfolio
- 6.11.5 UL Solutions Recent Developments
- 6.12 MED Institute
- 6.12.1 MED Institute Company Information
- 6.12.2 MED Institute Business Overview
- 6.12.3 MED Institute Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 MED Institute Cardiovascular Device Testing Service Product Portfolio
- 6.12.5 MED Institute Recent Developments
- 6.13 Eurofins Scientific
- 6.13.1 Eurofins Scientific Company Information
- 6.13.2 Eurofins Scientific Business Overview
- 6.13.3 Eurofins Scientific Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Eurofins Scientific Cardiovascular Device Testing Service Product Portfolio
- 6.13.5 Eurofins Scientific Recent Developments
- 6.14 Pharmaron
- 6.14.1 Pharmaron Company Information
- 6.14.2 Pharmaron Business Overview
- 6.14.3 Pharmaron Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Pharmaron Cardiovascular Device Testing Service Product Portfolio
- 6.14.5 Pharmaron Recent Developments
- 6.15 Pace Analytical
- 6.15.1 Pace Analytical Company Information
- 6.15.2 Pace Analytical Business Overview
- 6.15.3 Pace Analytical Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Pace Analytical Cardiovascular Device Testing Service Product Portfolio
- 6.15.5 Pace Analytical Recent Developments
- 6.16 Porsolt
- 6.16.1 Porsolt Company Information
- 6.16.2 Porsolt Business Overview
- 6.16.3 Porsolt Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Porsolt Cardiovascular Device Testing Service Product Portfolio
- 6.16.5 Porsolt Recent Developments
- 6.17 Medical Murray
- 6.17.1 Medical Murray Company Information
- 6.17.2 Medical Murray Business Overview
- 6.17.3 Medical Murray Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Medical Murray Cardiovascular Device Testing Service Product Portfolio
- 6.17.5 Medical Murray Recent Developments
- 6.18 Measurlabs
- 6.18.1 Measurlabs Company Information
- 6.18.2 Measurlabs Business Overview
- 6.18.3 Measurlabs Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Measurlabs Cardiovascular Device Testing Service Product Portfolio
- 6.18.5 Measurlabs Recent Developments
- 6.19 RQM+
- 6.19.1 RQM+ Company Information
- 6.19.2 RQM+ Business Overview
- 6.19.3 RQM+ Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 RQM+ Cardiovascular Device Testing Service Product Portfolio
- 6.19.5 RQM+ Recent Developments
- 6.20 Laboratory Testing
- 6.20.1 Laboratory Testing Company Information
- 6.20.2 Laboratory Testing Business Overview
- 6.20.3 Laboratory Testing Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Laboratory Testing Cardiovascular Device Testing Service Product Portfolio
- 6.20.5 Laboratory Testing Recent Developments
- 6.21 Infinity Laboratories
- 6.21.1 Infinity Laboratories Company Information
- 6.21.2 Infinity Laboratories Business Overview
- 6.21.3 Infinity Laboratories Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Infinity Laboratories Cardiovascular Device Testing Service Product Portfolio
- 6.21.5 Infinity Laboratories Recent Developments
- 6.22 Ibex Preclinical Research
- 6.22.1 Ibex Preclinical Research Company Information
- 6.22.2 Ibex Preclinical Research Business Overview
- 6.22.3 Ibex Preclinical Research Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Ibex Preclinical Research Cardiovascular Device Testing Service Product Portfolio
- 6.22.5 Ibex Preclinical Research Recent Developments
- 6.23 Innovatech Labs
- 6.23.1 Innovatech Labs Company Information
- 6.23.2 Innovatech Labs Business Overview
- 6.23.3 Innovatech Labs Cardiovascular Device Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Innovatech Labs Cardiovascular Device Testing Service Product Portfolio
- 6.23.5 Innovatech Labs Recent Developments
7 North America
- 7.1 North America Cardiovascular Device Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Cardiovascular Device Testing Service Market Size by Country (2021-2026)
- 7.3 North America Cardiovascular Device Testing Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Cardiovascular Device Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Cardiovascular Device Testing Service Market Size by Country (2021-2026)
- 8.3 Europe Cardiovascular Device Testing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cardiovascular Device Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Cardiovascular Device Testing Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Cardiovascular Device Testing Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Cardiovascular Device Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Cardiovascular Device Testing Service Market Size by Country (2021-2026)
- 10.3 South America Cardiovascular Device Testing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cardiovascular Device Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Cardiovascular Device Testing Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Cardiovascular Device Testing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst